NASDAQ:ICU SeaStar Medical (ICU) Stock Price, News & Analysis → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free ICU Stock Alerts $0.40 -0.14 (-25.69%) (As of 04/19/2024 ET) Add Compare Share Share Today's Range$0.38▼$0.5150-Day Range$0.41▼$1.4552-Week Range$0.16▼$2.28Volume7.47 million shsAverage Volume5.52 million shsMarket Capitalization$22.32 millionP/E RatioN/ADividend YieldN/APrice Target$5.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get SeaStar Medical alerts: Email Address SeaStar Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside1,119.5% Upside$5.00 Price TargetShort InterestBearish6.83% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.47Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.99 out of 5 starsMedical Sector787th out of 911 stocksSurgical & Medical Instruments Industry80th out of 97 stocks 3.5 Analyst's Opinion Consensus RatingSeaStar Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSeaStar Medical has received no research coverage in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.83% of the float of SeaStar Medical has been sold short.Short Interest Ratio / Days to CoverSeaStar Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SeaStar Medical has recently increased by 10.80%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSeaStar Medical does not currently pay a dividend.Dividend GrowthSeaStar Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ICU. Previous Next 2.5 News and Social Media Coverage News SentimentSeaStar Medical has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for SeaStar Medical this week, compared to 1 article on an average week.Search InterestOnly 19 people have searched for ICU on MarketBeat in the last 30 days. This is a decrease of -51% compared to the previous 30 days.MarketBeat Follows8 people have added SeaStar Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, SeaStar Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.50% of the stock of SeaStar Medical is held by insiders.Percentage Held by InstitutionsOnly 1.69% of the stock of SeaStar Medical is held by institutions. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of SeaStar Medical is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SeaStar Medical is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About SeaStar Medical Stock (NASDAQ:ICU)SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.Read More ICU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ICU Stock News HeadlinesApril 17, 2024 | globenewswire.comSeaStar Medical Reports 2023 Financial Results and Provides a Business UpdateApril 17, 2024 | msn.comSC National Guard conducts medical evacuation drill at Trident Medical CenterApril 19, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 15, 2024 | americanbankingnews.comSeaStar Medical Holding Co. (NASDAQ:ICU) Short Interest UpdateApril 12, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUApril 11, 2024 | finance.yahoo.comSeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity ConferenceApril 11, 2024 | globenewswire.comSeaStar Medical to Present at the Noble Capital Markets' Emerging Growth Virtual Healthcare Equity ConferenceApril 4, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUApril 19, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 28, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICUMarch 27, 2024 | globenewswire.comSeaStar Medical to Restate Financials, Sets Business Update Call for April 17March 12, 2024 | globenewswire.comSeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric PatientsMarch 11, 2024 | globenewswire.comSeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024February 27, 2024 | finance.yahoo.comManuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureFebruary 27, 2024 | globenewswire.comManuscript Discussing the Benefit of SeaStar Medical's Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart FailureFebruary 23, 2024 | benzinga.comSeaStar Medical Holding Stock (NASDAQ:ICU), Short Interest ReportFebruary 22, 2024 | markets.businessinsider.comSeaStar's Quelimmune Pediatric Device Gets Humanitarian Device Exemption From FDA; Stock DownFebruary 22, 2024 | finance.yahoo.comFDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney InjuryFebruary 22, 2024 | finance.yahoo.comNuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™February 22, 2024 | globenewswire.comFDA Grants Humanitarian Device Exemption Approval to SeaStar Medical's Selective Cytopheretic Device for Pediatric Acute Kidney InjuryFebruary 22, 2024 | investorplace.comUnleash Massive Returns With These 3 Top Penny StocksFebruary 10, 2024 | msn.comSeaStar Medical Faces Nasdaq Delisting ChallengeFebruary 1, 2024 | finance.yahoo.comSeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device TechnologyJanuary 31, 2024 | msn.comSeaStar Medical Secures $9M Through Strategic Securities AgreementJanuary 30, 2024 | benzinga.comSeaStar Medical Holding Stock (NASDAQ:ICU), Guidance and ForecastJanuary 26, 2024 | finance.yahoo.comSeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-MarketJanuary 12, 2024 | finanznachrichten.deSeaStar Medical Holding Corporation: SeaStar Medical Appoints David A. Green as Chief Financial OfficerSee More Headlines Receive ICU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2023Today4/19/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:ICU CUSIPN/A CIK1831868 Webseastarmedical.com Phone844-427-8100FaxN/AEmployees9Year FoundedN/APrice Target and Rating Average Stock Price Target$5.00 High Stock Price Target$5.00 Low Stock Price Target$5.00 Potential Upside/Downside+1,036.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.21) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,010,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-961.93% Debt Debt-to-Equity RatioN/A Current Ratio0.18 Quick Ratio0.18 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.64) per share Price / Book-0.69Miscellaneous Outstanding Shares55,120,000Free Float52,642,000Market Cap$24.24 million OptionableNot Optionable Beta-1.18 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Eric Schlorff (Age 51)CEO, President & Executive Director Comp: $690kDr. H. David Humes M.D.Co-Founder and Managing DirectorColonel Kevin Chung FACP (Age 51)M.D., Chief Medical Officer Comp: $375kMr. David A. Green CPA (Age 61)M.B.A., Chief Financial Officer Tom MullenVice President of Operations & Product DevelopmentKey CompetitorsLucid DiagnosticsNASDAQ:LUCDCo-DiagnosticsNASDAQ:CODXCarmellNASDAQ:CTCXCytosorbentsNASDAQ:CTSODarioHealthNASDAQ:DRIOView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 261,671 shares on 3/11/2024Ownership: 0.475%Vanguard Group Inc.Bought 261,671 shares on 2/15/2024Ownership: 0.475%Kestra Advisory Services LLCBought 52,550 shares on 2/14/2024Ownership: 0.148%Heel Kenneth VanBought 100,000 shares on 11/22/2023Total: $40,000.00 ($0.40/share)Kevin ChungBought 12,543 shares on 5/30/2023Total: $5,895.21 ($0.47/share)View All Insider TransactionsView All Institutional Transactions ICU Stock Analysis - Frequently Asked Questions Should I buy or sell SeaStar Medical stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SeaStar Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICU shares. View ICU analyst ratings or view top-rated stocks. What is SeaStar Medical's stock price target for 2024? 1 brokerages have issued twelve-month price targets for SeaStar Medical's shares. Their ICU share price targets range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 1,119.5% from the stock's current price. View analysts price targets for ICU or view top-rated stocks among Wall Street analysts. How have ICU shares performed in 2024? SeaStar Medical's stock was trading at $0.4427 at the beginning of 2024. Since then, ICU stock has decreased by 7.4% and is now trading at $0.41. View the best growth stocks for 2024 here. Are investors shorting SeaStar Medical? SeaStar Medical saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 3,590,000 shares, an increase of 10.8% from the March 15th total of 3,240,000 shares. Based on an average daily volume of 6,010,000 shares, the days-to-cover ratio is presently 0.6 days. Currently, 6.8% of the company's shares are short sold. View SeaStar Medical's Short Interest. When is SeaStar Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our ICU earnings forecast. How were SeaStar Medical's earnings last quarter? SeaStar Medical Holding Co. (NASDAQ:ICU) released its quarterly earnings data on Monday, August, 14th. The company reported ($0.25) earnings per share for the quarter. How do I buy shares of SeaStar Medical? Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ICU) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithTop 5 AI Stocks to Buy for 2024Market Moving Trends Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.